Interplay of Epidermal Growth Factor Receptor and Signal Transducer and Activator of Transcription 3 in Prostate Cancer: Beyond Androgen Receptor Transactivation

SIMPLE SUMMARY: Androgen receptor (AR) signaling mainly controls prostate cancer (PCa) growth. Hence, the conventional regimen for PCa includes androgen deprivation therapy (ADT) or antiandrogen in order to reduce PCa recurrence. However, castration-resistant prostate cancer (CRPC) is insensitive to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shian-Ren, Yeh, Hsiu-Lien, Liu, Yen-Nien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307975/
https://www.ncbi.nlm.nih.gov/pubmed/34298665
http://dx.doi.org/10.3390/cancers13143452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307975/
https://www.ncbi.nlm.nih.gov/pubmed/34298665
http://dx.doi.org/10.3390/cancers13143452

Ejemplares similares